Elkeles, R S <br/><br/>
Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study.  [electronic resource] 

 -  Diabetes care  Apr 1998 
 - 641-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0149-5992 
<br/><br/><label>Standard No.: </label>10.2337/diacare.21.4.641  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Bezafibrate--therapeutic use<br/>Carotid Arteries--diagnostic imaging<br/>Cholesterol--blood<br/>Cholesterol, HDL--blood<br/>Coronary Disease--diagnosis<br/>Diabetes Mellitus, Type 2--blood<br/>Diabetic Angiopathies--diagnosis<br/>Double-Blind Method<br/>Electrocardiography<br/>Exercise Test<br/>Female<br/>Femoral Artery--diagnostic imaging<br/>Fibrinogen--analysis<br/>Follow-Up Studies<br/>Humans<br/>Hypolipidemic Agents--therapeutic use<br/>Lipids--blood<br/>Lipoproteins--blood<br/>Male<br/>Middle Aged<br/>Placebos<br/>Time Factors<br/>Triglycerides--blood<br/>Ultrasonography